Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jiayu A. Tai"'
Autor:
Jiayu A. Tai, Tomoyuki Nishikawa, Hiroki Hayashi, Yu-Diao Kuan, Kunihiko Yamashita, Hironori Nakagami
Publikováno v:
Vaccines, Vol 12, Iss 7, p 757 (2024)
mRNA vaccines were successfully developed and approved for emergency use to fight coronavirus disease 2019. However, the effect of DNA vaccines against SARS-CoV-2 is considerably lower than that of mRNA vaccines. A pyro-drive jet injector (PJI) effic
Externí odkaz:
https://doaj.org/article/1edd1fb22a6e4332b2ed6b67e09910b0
Autor:
Hiroki Hayashi, Jiao Sun, Yuka Yanagida, Takako Otera, Jiayu A. Tai, Tomoyuki Nishikawa, Kunihiko Yamashita, Naoki Sakaguchi, Shota Yoshida, Satoshi Baba, Chin Yang Chang, Munehisa Shimamura, Sachiko Okamoto, Yasunori Amaishi, Hideto Chono, Junichi Mineno, Hiromi Rakugi, Ryuichi Morishita, Hironori Nakagami
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Emerging SARS-CoV-2 Omicron variants are highly contagious with enhanced immune escape mechanisms against the initially approved COVID-19 vaccines. Therefore, we require stable alternative-platform vaccines that confer protection against new
Externí odkaz:
https://doaj.org/article/7dffd246ebb04a9ab2662db39fb5d55f
Autor:
Chin Yang Chang, Jiayu A. Tai, Yuko Sakaguchi, Tomoyuki Nishikawa, Yayoi Hirayama, Kunihiko Yamashita
Publikováno v:
FEBS Open Bio, Vol 13, Iss 3, Pp 478-489 (2023)
Cell–cell fusion involves the fusion of somatic cells into a single hybrid cell. It is not only a physiological process but also an important cell engineering technology which can be applied to various fields, such as regenerative medicine, antibod
Externí odkaz:
https://doaj.org/article/1ff6a829e34f4204bd13a50092296ac0
Autor:
Hiroki Hayashi, Jiao Sun, Yuka Yanagida, Takako Otera, Miwa Sasai, Chin Yang Chang, Jiayu A. Tai, Tomoyuki Nishikawa, Kunihiko Yamashita, Naoki Sakaguchi, Shota Yoshida, Satoshi Baba, Munehisa Shimamura, Sachiko Okamoto, Yasunori Amaishi, Hideto Chono, Junichi Mineno, Hiromi Rakugi, Ryuichi Morishita, Masahiro Yamamoto, Hironori Nakagami
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a global pandemic. New technologies have been utilized to develop several types of vaccines to prevent the spread of SARS
Externí odkaz:
https://doaj.org/article/97fdc3e097c541348a429867b78bcc6e
Autor:
Tomoyuki Nishikawa, Chin Yang Chang, Jiayu A. Tai, Hiroki Hayashi, Jiao Sun, Shiho Torii, Chikako Ono, Yoshiharu Matsuura, Ryoko Ide, Junichi Mineno, Miwa Sasai, Masahiro Yamamoto, Hironori Nakagami, Kunihiko Yamashita
Publikováno v:
Immunological Medicine, Vol 45, Iss 4, Pp 251-264 (2022)
AbstractThere is an urgent need to stop the coronavirus disease 2019 (COVID-19) pandemic through the development of efficient and safe vaccination methods. Over the short term, plasmid DNA vaccines can be developed as they are molecularly stable, thu
Externí odkaz:
https://doaj.org/article/879d6157b7b742518b59d0accd9c4820
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss , Pp 175-186 (2021)
Breast cancer has a high risk of metastasis; however, no effective treatment has been established. We developed a novel immunotherapy for breast cancer to enhance cytotoxic T lymphocytes against cancer cells using N1-type neutrophils with anti-tumor
Externí odkaz:
https://doaj.org/article/24ee615b3a924a7d9f2f81d93db05149
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss, Pp 175-186 (2021)
Molecular Therapy Oncolytics
Molecular Therapy Oncolytics
Breast cancer has a high risk of metastasis; however, no effective treatment has been established. We developed a novel immunotherapy for breast cancer to enhance cytotoxic T lymphocytes against cancer cells using N1-type neutrophils with anti-tumor
Autor:
Jiayu A. Tai, Chikako Ono, Hiroki Hayashi, Ryoko Ide, Shiho Torii, Hironori Nakagami, Tomoyuki Nishikawa, Masahiro Yamamoto, Chin Yang Chang, Yamashita Kunihiko, Junichi Mineno, Yoshiharu Matsuura, Jiao Sun, Miwa Sasai
There is an urgent need to limit and stop the worldwide coronavirus disease 2019 (COVID-19) pandemic via quick development of efficient and safe vaccination methods. Plasmid DNA vaccines are one of the most remarkable vaccines that can be developed i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::089f23d7e627ea3c5603a40634061fe3
https://doi.org/10.1101/2021.01.13.426436
https://doi.org/10.1101/2021.01.13.426436
Publikováno v:
Cancer gene therapy. 27(6)
Inactivated Sendai virus particle (or hemagglutinating virus of Japan envelope; HVJ-E) has been previously reported to possess antitumour properties that activate antitumour immunity. Two glycoproteins, fusion (F) and hemagglutinin-neuraminidase (HN)
Publikováno v:
Oncotarget
// Chin Yang Chang 1 , Jiayu A. Tai 1 , Sumin Li 1 , Tomoyuki Nishikawa 1 , Yasufumi Kaneda 1 1 Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan Correspondence to: Yasufumi Kaneda, email: k